WITHDRAWN: In vitro and in vivo evaluation of azilsartan tablets prepared by wet grinding combined with spray-drying and jet milling: Comparison with marketed tablets

De R, Harper R, Cuculi F. Critical evaluation of the efficacy and tolerability of azilsartan. Vasc Health Risk Manag. 2012; 8: 299-305. Kusumoto K, Igata H, Ojima M, et al. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type1 receptor blocker, azilsartan medoxomil, in rat and dog models. Eur J Pharmacol. 2011;669: 84-93. Zaiken K, Cheng J. Azilsartan medoxomil: a new Angiotensin receptor blocker. Clin Ther. 2011;33: 1577-1589.